SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 92.39 |
| Enterprise Value ($M) | 126.93 |
| Book Value ($M) | -322.40 |
| Book Value / Share | -11.76 |
| Price / Book | -0.29 |
| NCAV ($M) | -499.46 |
| NCAV / Share | -18.22 |
| Price / NCAV | -0.18 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.74 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.11 |
| Current Ratio | 0.11 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 23.14 |
| Assets | 200.20 |
| Liabilities | 522.60 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 103.46 |
| Operating Income | -124.43 |
| Net Income | -227.21 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -158.31 |
| Cash from Investing | 0.03 |
| Cash from Financing | 122.84 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Deep Track Capital, LP | 0.00 | -100.00 | |
| 13G/A | Point72 Asset Management, L.P. | 0.10 | -99.92 | |
| 13G | BlackRock, Inc. | 7.30 | 0.00 | |
| 13G/A | Vanguard Group Inc | 10.24 | -92.90 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 181,597 | 666,930 | 27.23 | |
| 199,393 | 523,015 | 38.12 | |
| 231,397 | 720,235 | 32.13 | |
| 816,577 | 3,119,024 | 26.18 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ADIL – Adial Pharmaceuticals, Inc. | ADTX – Aditxt, Inc. |
| ADVM – Adverum Biotechnologies, Inc. | AIMD – Ainos, Inc. |
| AKAN – Akanda Corp. |